072020 — Choong Ang Vaccine Laboratory Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩83bn
- KR₩66bn
- KR₩49bn
Annual cashflow statement for Choong Ang Vaccine Laboratory Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7,602 | 4,044 | 5,998 | 6,850 | 6,157 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -1,698 | 1,774 | 2,240 | 542 | 1,902 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 616 | -4,787 | -1,045 | 472 | -6,510 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11,525 | 7,086 | 12,706 | 13,402 | 7,871 |
| Capital Expenditures | -14,366 | -7,170 | -1,918 | -7,170 | -5,976 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2,366 | -2,012 | -1,505 | -2,848 | 1,554 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12,000 | -9,181 | -3,423 | -10,018 | -4,422 |
| Financing Cash Flow Items | — | — | — | 0.859 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -877 | -1,600 | -2,813 | -4,778 | -6,482 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -944 | -3,489 | 6,541 | -926 | -2,993 |